|
Today's Headlines
There is considerable discrepancy among caregivers and pharmacists regarding the appropriate dosage of acetaminophen for overweight and obese children, according to a recent study published online in the European Journal of Hospital Pharmacy Science and Practice. » Full article
|
|
Anticoagulant therapy, particularly the use of aspirin, may reduce the risk of prostate cancer-specific mortality in men treated with radical prostatectomy or radiotherapy for prostate cancer, according to a study published online in the Journal of Clinical Oncology. » Full article
|
|
Recommendations for the 2012-2013 influenza season were recently published by the Advisory Committee on Immunization Practices. The recommendations include an updated vaccination schedule for children and information on virus strains, seizures, and egg allergy. » Full article
|
|
Prasugrel may not improve outcomes for patients under the age of 75 years with unstable angina or non-ST-segment elevation myocardial infarction who have not undergone revascularization, according to a study published in the New England Journal of Medicine. » Full article
|
|
Caffeine may offer promise to patients with Parkinson disease, according to a small study published in Neurology. » Full article
|
|
CONTINUING EDUCATION
Welcome to a new CPE series: Medication Therapy Management (MTM) in Patients with Diabetes, which has been designed for pharmacists who take care of patients with diabetes. You can earn up to 14 CPE credits from September 2012-March 2013 with 7 monthly knowledge-based activities. This month, the professional development activity will cover the pathophysiology, diagnosis, screening, and risk factors associated with diabetes mellitus.
To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.
|
|
EDITOR'S PICK
Baby boomers may soon add hepatitis C to their list of routine annual screenings when a proposed expansion of current Centers for Disease Control and Prevention guidelines is put into place.
» Full article
|
Survey
a) Further broaden the gap between copay dollar value between preferred and non-preferred brand drug tiers.
b) Demand increase formulary rebates requested from manufacturers of preferred products.
c) Implement more aggressive utilization management (PA, Step, Therapeutic Interchange, etc.) to specifically target these products.
d) Enhanced employment of a closed-formulary benefit design.
e) No action, as I don't believe this couponing will have significant effects.
Respond here and see what your colleagues think too.Want to see the results of our last survey regarding preventive services legislation? Click here.
|
|
|
Like
Tweet
